🇺🇸 Fibrinogen in United States

370 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 58 reports (15.68%)
  2. Drug Ineffective — 57 reports (15.41%)
  3. Foetal Exposure During Pregnancy — 40 reports (10.81%)
  4. Hypotension — 34 reports (9.19%)
  5. Shock Haemorrhagic — 34 reports (9.19%)
  6. Maternal Exposure During Pregnancy — 31 reports (8.38%)
  7. Pleural Effusion — 30 reports (8.11%)
  8. Blood Pressure Increased — 29 reports (7.84%)
  9. Pneumonia — 29 reports (7.84%)
  10. Foetal Growth Restriction — 28 reports (7.57%)

Source database →

Fibrinogen in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Fibrinogen approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fibrinogen in United States?

Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.